Oncology
Researchers' findings advance oncology research
Published in Hepatitis Weekly, July 18th, 2005
Study 1: Triple combination therapy cannot arrest advanced liver cancer growth.
According to recent research from Italy, "thalidomide, an antiangiogenic agent, does not have a good therapeutic effect for advanced hepatocellular carcinoma when used alone. Megestrol and interleukin-2 have been proposed as a palliative treatment for hepatocellular carcinoma. We assessed the effectiveness/safety of a combined therapy with thalidomide + megestrol + interleukin-2 in cirrhotic patients with advanced hepatocellular carcinoma."
"Nine cirrhotic patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-07-18)
More Articles from Hepatitis Weekly
- Cancer Prevention
Selenium levels relate inversely to liver cancer occurrence - Drug Development
PEG-interferon may trigger reversible hair loss in patients with hepatitis C - Drug Development
Transient replicon-based assay tracks NS5B response to hepatitis C inhibitors - Hepatitis C Therapy
Antiviral response endures in children with chronic hepatitis C - Hepatitis C Virus
Alpha-smooth muscle actin monitors patients for early liver cirrhosis - Addiction Medicine
New findings in the area of addiction medicine described - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
